SELE and breast carcinoma: Although identification of a ubiquitous E-selectin ligand expressed by multiple breast cancer cell lines is lacking, many breast cancer cell lines have been previously shown to possess E-selectin ligand activity [7], [8], [23], [24], [25], [26].